Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Hoffmann-La Roche Stories

2012-11-12 16:24:22

INDIANAPOLIS, Nov. 12, 2012 /PRNewswire/ -- Roche Diagnostics, a world leader in pharmaceuticals and diagnostics, announced in June its plans to invest $300 million during the next 10 years in expanding its North American headquarters located on the northeast side of Indianapolis. The first phase of the project is a new Learning and Development Center, where approximately 1,500 customers from across the nation will be trained each year. Mayor Greg Ballard will be joined by Roche...

2012-10-09 04:04:00

According to court documents, on June 1st, 2012, the lawsuit of Andrew Boatright v Hoffman-La Roche was removed by the defendants to federal court (case no. 2:2012cv03115, Pennsylvania Eastern District Court). Plaintiff claims he was diagnosed with Crohn´s disease after taking Accutane. Accutane (isotretinoin), a popular acne medication, was introduced in 1982 and in 2009 as the number of lawsuits against Hoffman-LaRoche kept increasing the drug was pulled from the US market. Now,...

2012-09-20 02:29:01

PASADENA, Calif., Sept. 20, 2012 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is honored to announce that Roche Holding Ltd will establish its new Translational Clinical Research Center (TCRC) at the Alexandria Center for Life Science - New York City. The TCRC will be the mission-critical presence for Roche Pharma Research and Early...

2012-09-18 06:28:54

EXTON, Pa., Sept. 18, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) announced today that the company will provide a live audio and slide webcast of its analyst and investor seminar, focusing on the company's commercial product projections and future growth opportunities on Friday, September 21, 2012. Lectures will be provided by a number of ViroPharma representatives. The seminar, entitled "Broadening Horizons," will be held from 9:00 A.M. until 12:45 P.M. Eastern Time on...

2012-09-13 23:25:40

Drugs prescribed to treat anxiety, depression and insomnia may increase patients' risk of being involved in motor vehicle accidents, according to a recent study, published in the British Journal of Clinical Pharmacology. Based on the findings, the researchers suggested doctors should consider advising patients not to drive while taking these drugs. Psychotropic drugs affect the way the brain functions and can impair a driver's ability to control their vehicle. Research on the links between...

2012-09-10 02:29:16

MIAMI, Sept. 10, 2012 /PRNewswire/ -- Nuovo Biologics, LLC announced that Robert G. Savage has joined its Board. Mr. Savage served as Group Vice President and President - General Therapeutics & Inflammation Business of Pharmacia Corporation from 2002 until its acquisition by Pfizer, Inc. in 2003. From 1996 through 2001, Mr. Savage served Johnson & Johnson in a variety of roles, most recently as Worldwide Chairman of Johnson and Johnson's Pharmaceutical Group. From 1985 to 1996 he...

2012-09-06 23:00:43

According to court documents, on May 21st, 2012, California woman Hannah R. Scroggins filed a lawsuit in California Northern District Court (case no. 3:2012cv02615) alleging she suffered serious, including inflammatory bowel disease, after taking Accutane. Accutane (isotretinoin), a popular acne medication, was introduced in 1982 and in 2009 as the number of lawsuits against Hoffman-LaRoche kept increasing the drug was pulled from the US market. Now, AttorneyOne.com, a recognized authority on...

2012-09-05 23:03:54

ReportsnReports.com adds new market research report “PCR 2012: Market Needs, Emerging Developments and Future Use” to its store. Dallas, TX (PRWEB) September 04, 2012 This study involved the participation of more than 600 experienced PCR users and decision-makers in 75 countries. It investigated PCR methods, companies and products, their strengths and weaknesses, current and future annual budgets, budget breakdown, consumables, challenges, innovation, biomarkers, bioinformatics...

2012-08-09 23:00:52

As Bloomberg reported on June 30th 2012, a New Jersey jury ruled that Hoffman-LaRoche must pay $18 million in damages to two former Accutane users, Kathleen Rossitto and Riley Wilkinson (case no. ATL-l-7481-10-MT and ATL-L-1311-08-MT). Accutane (isotretinoin), manufactured by Hoffman-LaRoche, Inc., is a popular acne medication introduced in 1982. In 2009, as the number of lawsuits against Hoffman-LaRoche kept increasing, Accutane was pulled from the US market. Now, AttorneyOne.com, a...

2012-07-31 02:27:49

PENZBERG, Germany, July 31, 2012 /PRNewswire/ -- Roche and SynenTec today announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System. This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optimal support and development of the technology for its customers. The Cellavista Imaging System for noninvasively measuring cell...